ABCC4 polymorphism indirectly reduces systemic exposure to a capecitabine metabolite 5′‐deoxy‐5‐fluorouridine in Japanese subjects - Matsumoto, Natsumi; Oishi, Ayano; Yoshino, Shotaro; Masuo, Yusuke; Kubota, Yutaro; Ishida, Hiroo; Shimada, Ken; Kato, Yukio; Fujita, Ken‐ichi (British journal of clinical pharmacology, 2025)
Keywords: pharmacokinetics; ABCC4; capecitabine; polymorphism; cyclic adenosine monophosphate; thymidine phosphorylase